Top Stories
-
Columbia-led clinical trial addresses important barrier to opioid use disorder treatment.
Topic
-
Ryan Lawrence, MD, director of the Comprehensive Psychiatric Emergency Program, discusses what individuals can expect during an ER visit.
Topic
-
Columbia-led study hold promise for helping people find therapies that work.
Topic
-
Studies indicate that 29% to 46% of patients diagnosed with major depressive disorder show partial or no response to treatments.
Topic
Latest News
-
Source:
Men's JournalJanuary 9, 2020“You may need to go back for a second or third session before you get a sense of whether it’s a good fit for you,” says Dr. Ravi N. Shah.
Topic
-
Source:
MD MagazineJanuary 8, 2020In an accompanying editorial, Dr. Joshua T. Kantrowitz explained how the future role of lumateperone could be crucial in treating schizophrenia patients.
-
Source:
OutsideJanuary 1, 2020Dr. Michael Grunebaum says that in his clinical trials, many patients don’t find that the drug relieves anxiety. “Ketamine is just a really distinct, weird, spacey feeling,” he says.
Topic
-
Source:
The Science of PsychotherapyDecember 31, 2019A discussion with Dr. Deborah Cabaniss and Dr. Yael Holoshitz about their new book Different Patients, Different Therapies: Optimizing Treatment Using Differential Psychotherapuetics.
Topic
-
Source:
MD MagazineDecember 23, 2019“The efficacy and safety profile of CAPLYTA approved by the FDA, offers healthcare providers an important new option for treating people living with schizophrenia,” said Dr. Jeffrey A. Lieberman.
-
Source:
Los Angeles TimesDecember 16, 2019The study suggests that some of the ways schools cope with student suicides might prove useful in the aftermath of a school shooting, Dr. Mark Olfson said.
Topic
-
Source:
HealthlineDecember 12, 2019Dr. Elias Dakwar said he became interested in ketamine as a potential treatment for alcohol use disorder after seeing good results from using the drug to treat cocaine addiction.
Topic
- December 5, 2019
Researchers findings at Columbia University Vagelos College of Physicians and Surgeons and New York State Psychiatric Institute could lead to a new approach to the treatment of alcohol use disorder.
Topic
-
Source:
Philly VoiceDecember 5, 2019"In our participants, ketamine appears to have increased resilience and reduced demoralization after a lapse," Dr. Elias Dakwar said.
Topic
-
Source:
FilterDecember 5, 2019Dr. Elias Dakwar has conducted laboratory and clinical investigations of ketamine infusion and mindfulness training to treat cocaine use disorder.
Topic
